Effects of inhibition of the renin‐angiotensin system on the cardiovascular actions of insulin
2000; Wiley; Volume: 2; Issue: 1 Linguagem: Inglês
10.1046/j.1463-1326.2000.00044.x
ISSN1463-1326
AutoresMichael J. Katovich, Alok S. Pachori,
Tópico(s)Diet and metabolism studies
ResumoDiabetes, Obesity and MetabolismVolume 2, Issue 1 p. 3-14 Effects of inhibition of the renin-angiotensin system on the cardiovascular actions of insulin Michael J. Katovich, Michael J. Katovich Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610Search for more papers by this authorAlok Pachori, Alok Pachori Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610Search for more papers by this author Michael J. Katovich, Michael J. Katovich Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610Search for more papers by this authorAlok Pachori, Alok Pachori Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL 32610Search for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1463-1326.2000.00044.xCitations: 21 Dr Michael J. Katovich, Professor, Department of Pharmacodynamics, College of Pharmacy, PO Box 100487, Gainesville, Fl 32610, USA. E-mail:katovich@cop.ufl.edu Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Modan, M, Halkin, H, Almog, S et al. Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 1985; 75, 809 817. 10.1172/JCI111776 CASPubMedWeb of Science®Google Scholar 2 Ferrannini, E & Natali, A. Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 1991; 4, 1274 1282. 10.1016/0002-8703(91)90433-I Web of Science®Google Scholar 3 Ferrari, P & Weidmann, P. Insulin, insulin sensitivity and hypertension. J Hyperten 1990; 8, 491 500. 10.1097/00004872-199006000-00001 CASPubMedWeb of Science®Google Scholar 4 Weidmann, P, Bohlen, L, De Courten, M. Insulin resistance and hyperinsulinemia in hypertension. J Hypertens 1995; 13 (Suppl.), S65 S72. 10.1097/00004872-199508001-00010 CASPubMedWeb of Science®Google Scholar 5 Reaven, GL. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991; 90 (Suppl.), 7S 12S. 10.1016/0002-9343(91)90028-V CASPubMedWeb of Science®Google Scholar 6 Reaven, G.M. Insulin and hypertension. Clin Exper Hyper 1990; 12, 803 816. 10.3109/10641969009073501 CASPubMedWeb of Science®Google Scholar 7 Sowers, JR, Standley, PR, Ram, JL, Jacober, S, Simpson, I, Rose, K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993; 6, 260S 270S. CASPubMedWeb of Science®Google Scholar 8 Sowers, JR, Sowers, PS, Peuler, JD. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 1994; 123, 647 652. CASPubMedWeb of Science®Google Scholar 9 Swislocki, ALM, Hoffman, BB, Reaven, GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 2, 419 423. 10.1093/ajh/2.6.419 PubMedWeb of Science®Google Scholar 10 DeFronzo, RA & Ferrannini, E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14, 173 194. 10.2337/diacare.14.3.173 CASPubMedWeb of Science®Google Scholar 11 Krieger, DL & Lansberg, L. Mechanisms of obesity-related Hypertension: role of insulin and catecholamines. Am J Hypertens 1998; 1, 84 90. Google Scholar 12 DeFronzo, R, Felig, P, Ferrannini, E, Wahren, J. Effect of graded doses ofsulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol 1980; 238, E421 E427. CASPubMedWeb of Science®Google Scholar 13 DeFronzo, R.A. Insulin and renal sodium handling: clinical implications. Int J Obesity 1981; 5, 93 104. PubMedWeb of Science®Google Scholar 14 Saudek, CD, Boulter, PR, Knopp, RH, Arky, RA. Sodium retention accompanying insulin treatment of diabetes mellitus. Diabetes 1974; 23, 240 246. 10.2337/diab.23.3.240 CASPubMedWeb of Science®Google Scholar 15 Rowe, JW, Young, JB, Minaker, KL et al. Effect of insulin and glucose infusions on sympathetic activity in normal man. Diabetes 1981; 30, 219 255. 10.2337/diab.30.3.219 CASPubMedWeb of Science®Google Scholar 16 Berne, C, Fagius, J, Niklasson, F. Sympathetic response to oral carbohydrate administration: evidence from microelectrode nerve recordings. J Clin Invest 1989; 84, 1403 1409. 10.1172/JCI114313 CASPubMedWeb of Science®Google Scholar 17 Landsberg, L & Krieger, DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens 1989; 2, 1255 1325. Google Scholar 18 Berne, C, Fagius, J, Pollare, T, Hjemdahl, P. The sympathetic response to euglycaemic hyperinsulinemia. Diabetologia 1992; 35, 873 879. 10.1007/BF00399935 CASPubMedWeb of Science®Google Scholar 19 Ward, KD, Sparrow, D, Vokonas, PS, Willett, WC, Landberg, L, Weiss, ST. The relationships of abdominal obesity hyperinsulinemia and saturated fat intake to serum lipid levels: the Normative Aging Study. Int J Obes Relat Metab Disord 1994; 18, 137 144. CASPubMedWeb of Science®Google Scholar 20 Nickenig, G & Bohm, M. Interaction between insulin and AT1 receptor: relevance for Hypertension and arteriosclerosis. Basic Res Cardiol 1998; 93 (Suppl.), 135 139. 10.1007/s003950050240 CASPubMedWeb of Science®Google Scholar 21 Ross, R & Glomset, JA. Atherosclerosis and the arterial smooth muscle cell. Science 1973; 180, 1332 1229. 10.1126/science.180.4093.1332 CASPubMedWeb of Science®Google Scholar 22 Cruz, AB, Amatuzio, DS, Grande, F, Kay, LJ. Effect oftra-arterial insulin on tissue cholesterol and fatty acid synthesis in alloxan diabetic dogs. Circ Res 1961; 9, 39 43. 10.1161/01.RES.9.1.39 CASPubMedWeb of Science®Google Scholar 23 Banskota, NK, Taub, R, Zellner, K, Olsen, P, King, GL. Characterisation ofduction of protooncogene C-MYC and cellular growth in human vascular smooth muscle cells by insulin and IGF-1. Diabetes 1989; 38, 123 129. 10.2337/diabetes.38.1.123 CASPubMedWeb of Science®Google Scholar 24 Murakami, E, Hiwada, K, Kokubu, T. Effect of insulin and glucagon on production of renin substrate by the isolated rat liver. J Endocrinol 1980; 85, 151 153. 10.1677/joe.0.0850151 CASPubMedWeb of Science®Google Scholar 25 Trovati, M, Massucco, P, Anfossi, G et al. Insulin influences the renin-angiotensin-aldosterone system in humans. Metabolism 1989; 38, 501 503. 10.1016/0026-0495(89)90207-2 CASPubMedWeb of Science®Google Scholar 26 Jost-Vu, E, Horton, R, Antonipillai, I. Altered regulation of renin secretion by insulin like growth factors and angiotensin II in diabetic rats. Diabetes 1992; 41, 1100 1105. 10.2337/diabetes.41.9.1100 CASPubMedWeb of Science®Google Scholar 27 Cassis, LA. Downregulation of the renin-angiotensin system in streptozotocin-diabetic rats. Am J Physiol 1992; 262, E105 E109. CASPubMedWeb of Science®Google Scholar 28 Cheng, HF, Burns, KD, Harris, RC. Reduced proximal tubule angiotensin receptor expression in streptozotocin-induced diabetes mellitus. Kidney Int 1994; 46, 1603 1610. 10.1038/ki.1994.458 CASPubMedWeb of Science®Google Scholar 29 Ballerman, BJ, Skorecki, KL, Brenner, BM. Reduced glomerular angiotensin II receptor density in early untreated diabetes in the rat. Am J Physiol 1984; 247, F110 F116. PubMedWeb of Science®Google Scholar 30 Sowers, JR. Is hypertension an insulin-resistant state? Metabolic changes associated with hypertension and antihypertensive therapy. Am Heart J 1991; 122, 932 935. 10.1016/0002-8703(91)90814-X CASPubMedWeb of Science®Google Scholar 31 Baron, AD, Brechtel-Hook, G, Johnson, A, Hardin, D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 1993; 21, 129 135. 10.1161/01.HYP.21.2.129 PubMedWeb of Science®Google Scholar 32 Laakso, M, Edelman, SV, Brechtel, G, Baron, AD. Decreased effect ofsulin to stimulate skeletal muscle blood flow in obese men: a novel mechanism for insulin resistance. J Clin Invest 1990; 85, 1844 1852. 10.1172/JCI114644 PubMedWeb of Science®Google Scholar 33 Udea, Y, Aoi, W, Yamachika, S, Shikaya, T. Beneficial effects of angiotensin converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension. Nephron 1990; 55, 85 89. 10.1159/000186043 PubMedWeb of Science®Google Scholar 34 Feman, SS, Mericle, RA, Reed, GW, May, JM, Workman, RJ. Serum angiotensin converting enzyme in diabetic patients. Am J Med Sci 1993; 305, 280 284. 10.1097/00000441-199305000-00002 CASPubMedWeb of Science®Google Scholar 35 Hallab, M, Berrut, G, Bouhanick, B et al. Increase in serum angiotensin converting enzyme activity after oral glucose loading. J Hypertens 1992; 10, 1296. 10.1097/00004872-199210000-00050 Google Scholar 36 Iimura, O, Shimamoto, K, Matsuda, K et al. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives. Am J Hypertens 1995; 8, 352 357. 10.1016/0895-7061(94)00245-7 Web of Science®Google Scholar 37 Folli, F, Kahn, CR, Hansen, H, Bouchie, JL, Feener, EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at mutipile levels. J Clin Invest 1997; 100, 2158 2169. 10.1172/JCI119752 CASPubMedWeb of Science®Google Scholar 38 Carvallho, CRO, Thirone, ACP, Gontijo, JAR, Velloso, LA, Saad, MJ. Effect of captopril, Losartan, and bradykinin on early steps of insulin action. Diabetes 1997; 46, 1950 57. 10.2337/diabetes.46.12.1950 PubMedWeb of Science®Google Scholar 39 Fang, T-C & Huang, W-C. Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. Hypertension 1998; 32, 235 242. 10.1161/01.HYP.32.2.235 CASPubMedWeb of Science®Google Scholar 40 Fang, TC & Huang, WC. Role of angiotensin II in hyperinsulinemia-induced Hypertension in rats. J Hypertens 1998; 16, 1767 1774. 10.1097/00004872-199816120-00009 CASPubMedWeb of Science®Google Scholar 41 Nakata, T, Takeda, K, Hatta, T et al. Blockade of angiotensin II receptors inhibits the increae in blood pressure induced by insulin. J Cardiovas Pharmacol 1998; 31, 248 252. 10.1097/00005344-199802000-00010 CASPubMedWeb of Science®Google Scholar 42 Townsend, RR & DiPette, DJ. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normontensive men. Am J Physiol 1993; 265, E362 E366. 10.1152/ajpendo.1993.265.3.E362 CASPubMedWeb of Science®Google Scholar 43 Keen, HL, Brands, MW, Smith, MJ, Hall, JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension 1998; 31, 637 642. 10.1161/01.HYP.31.2.637 CASPubMedWeb of Science®Google Scholar 44 Fliser, D, Schaefer, F, Schmid, D, Veldhuis, JD, Ritz, E. Angiotensin II affects basal, pulsatile, and glucose stimulated insulin secretion in humans. Hypertension 1997; 30, 1156 1161. 10.1161/01.HYP.30.5.1156 CASPubMedWeb of Science®Google Scholar 45 Widgren, BR, Urbanavicius, V, Wikstrand, J, Attvall, S, Persson, B. Low dose angiotensin-II increases glucose disposal rate during euglycemic hyperinsulinemia. Am J Hypertens 1993; 6, 892 895. 10.1093/ajh/6.10.892 CASPubMedWeb of Science®Google Scholar 46 Taddei, S, Virdis, A, Mattei, P et al. Vascular renin-angiotensin system and sympathetic nervous system activity in human hypertenison. J Cardiovasc Pharmacol 1994; 23 (Suppl.): s9-s14. PubMedWeb of Science®Google Scholar 47 Rao, RH. Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats. Am J Hypertens 1994; 7, 655 660. 10.1093/ajh/7.7.655 CASPubMedWeb of Science®Google Scholar 48 Machado, LJC, Mihessen-Neto, I, Marubayashi, R, Reis, AM, Coimbra, CC. Hyperglycemic action of angiotensin II in freely moving rats. Peptides 1995; 16, 479 483. 10.1016/0196-9781(95)00007-7 CASPubMedWeb of Science®Google Scholar 49 Pollare, T, Lithell, H, Berne, C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism on patients with Hypertension. New Engl J Med 1998; 121, 868 873. Google Scholar 50 Shamiss, A, Carrol, J, Rosenthal, T. Insulin resistance in secondary hypertension. Am J Hypertens 1992; 5, 26 28. 10.1093/ajh/5.1.26 CASPubMedWeb of Science®Google Scholar 51 Gans, ROB & Donker, AJM. Insulin and blood pressure regulation. J Int Med 1991; 229 (Suppl.), 49 64. Web of Science®Google Scholar 52 Shen, DC, Shieh, SM, Fuh, MT et al. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66, 580 583. 10.1210/jcem-66-3-580 PubMedWeb of Science®Google Scholar 53 Reisin, E, Abel, R, Modan, M et al. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl J Med 1978; 298, 1 6. 10.1056/NEJM197801052980101 CASPubMedWeb of Science®Google Scholar 54 Muntzel, M, Beltz, T, Mark, AL, Johnson, AK. Anteroventral third ventricle lesions abolish lumbar sympathetic response to insulin. Hypertension 1994; 23, 1059 1062. 10.1161/01.HYP.23.6.1059 CASPubMedWeb of Science®Google Scholar 55 Fink, GD, Haywood, JR, Bryan, WJ et al. Central site for pressor action of blood-borne angiotensin in rat. Am J Physiol 1980; 239, R358 R361. CASPubMedWeb of Science®Google Scholar 56 Hall, JE, Brands, MW, Kivlighn, SD et al. Chronic hyperinsulinemia and blood pressure: Interaction with catecholamines? Hypertension 1990; 15, 519 527. 10.1161/01.HYP.15.5.519 CASPubMedWeb of Science®Google Scholar 57 Reubi, FC, Weidmann, P, Hodler, J et al. Changes in renal function in essential hypertension. Am J Med 1978; 64, 556 563. 10.1016/0002-9343(78)90573-9 CASPubMedWeb of Science®Google Scholar 58 Rocchini, AP, Key, J, Bondie, D, Chico, R et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. New Engl J Med 1989; 321, 580 585. 10.1056/NEJM198908313210905 CASPubMedWeb of Science®Google Scholar 59 Tedde, R, Sechi, LA, Marigliano, A, Pala, A, Scano, L. Anti-hypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens 1989; 2, 163 172. CASPubMedWeb of Science®Google Scholar 60 Mbanya, JC, Thomas, THE, Taylor, R, Alberti, KG, Wilkinson, R. Increased proximal tubular sodium reabsorption in Hyper-tensionive patients with type II diabetes. Diabetic Med 1989; 6, 614 620. 10.1111/j.1464-5491.1989.tb01238.x CASPubMedWeb of Science®Google Scholar 61 Chevalier, RL, Thornhill, BA, Belmonte, DC, Baertschi, AJ. Endogenous angiotensin II inhibits natriuresis after acute, expansion in the neonatal rat. Am J Physiol 1996; 2270, R393 R397. Google Scholar 62 Cleland, SJ, Petrie, JR, Ueda, S, Elliott, HL, Connell, JM. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clin Exper Pharmacol Physiol 1998; 25, 175 184. 10.1111/j.1440-1681.1998.t01-15-.x CASPubMedWeb of Science®Google Scholar 63 Hall, JE, Brands, MW, Zappe, DH, Alonso-Galicia, M. Cardiovascular actions of insulin: are they important in long-term blood pressure regulation? Clin Exper Pharmacol Physiol 1995; 22, 689 700. 10.1111/j.1440-1681.1995.tb01922.x CASPubMedWeb of Science®Google Scholar 64 Creager, MA, Liang, C-S, Coffman, JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985; 235, 709 714. CASPubMedWeb of Science®Google Scholar 65 Yki-Jarvinen, H & Utriainen, T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 1998; 41, 369 379. 10.1007/s001250050919 CASPubMedWeb of Science®Google Scholar 66 Edelson, GW & Sowers, JR. Insulin resistance in hypertension: a focused review. Am J Med Sci 1993; 306, 345 347. 10.1097/00000441-199311000-00014 CASPubMedWeb of Science®Google Scholar 67 Nickening, G, Roling, J, Strehlow, K, Schnabel, P, Bohm, M. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation 1998; 98, 2453 2460. 10.1161/01.CIR.98.22.2453 PubMedWeb of Science®Google Scholar 68 Gaboury, CL, Simonson, DC, Seely, EW, Olsen, P, King, GL. Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest 1994; 94, 2295 2300. 10.1172/JCI117593 CASPubMedWeb of Science®Google Scholar 69 Banskota, NK, Taub, R, Zellner, K, Olsen, P, King, GL. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-1. Diabetes 1989; 38, 123 129. 10.2337/diabetes.38.1.123 CASPubMedWeb of Science®Google Scholar 70 Stout, RW, Bierman, E, Ross, R. Effect ofsulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975; 36, 318 327. 10.1161/01.RES.36.2.319 Google Scholar 71 Li, JS, Sharifi, AM, Schriffrin, EL. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. J Cardiovasc Pharmacol 1997; 30, 75 83. 10.1097/00005344-199707000-00011 CASPubMedWeb of Science®Google Scholar 72 King, GL, Goodman, DA, Buzney, S, Moses, A, Kahn, CR. Receptors and growth promoting effects of insulin and insulin like growth factors in cells from bovine retinal capillaries and aorta. J Clin Invest 1985; 75, 1028 1036. 10.1172/JCI111764 CASPubMedWeb of Science®Google Scholar 73 Paquet, J, Baudoin-Legros, M, Brunelle, G, Meyer, P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990; 8, 565 572. 10.1097/00004872-199006000-00010 CASPubMedWeb of Science®Google Scholar 74 Dubey, RK, Flammer, J, Luscher, TF. Angiotensin II and insulin induce growth of ciliary arterty smooth muscle: effects of AT1/AT2 antagonists. Invest Ophthal Vis Sci 1998; 39, 2067 2075. CASPubMedWeb of Science®Google Scholar 75 Keidar, S, Attias, J, Smith, J, Breslow, JL, Hayek, T. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atheroclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Comm 1997; 30, 622 625. 10.1006/bbrc.1997.6844 Web of Science®Google Scholar 76 Keidar, S. & Angiotensin, LDL. peroxidation and atherosclerosis. Life Sci 1998; 63, 1 11. 10.1016/S0024-3205(98)00014-9 CASPubMedWeb of Science®Google Scholar 77 Culman, J, Hartling, S., Von Heyer, C, Rascher, W, Unger, T. Effects of irbesartan and losartan administered peripherally or centrally on vasopressin release, drinking response, and c-fos expression in the rat brain. J Hypertens 1998; 16, S114. Web of Science®Google Scholar 78 Azuma, H, Niimi, Y, Hamasaki, H. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, losartan. Br J Pharmacol 1992; 106, 665 671. 10.1111/j.1476-5381.1992.tb14392.x CASPubMedWeb of Science®Google Scholar 79 Black, HR. The coronary artery disease paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy. J Cardiovasc Pharmacol 1990; 1 (Suppl.), S26 S38. 10.1097/00005344-199000005-00005 Google Scholar 80 Moan, A, Os, I, Kjeldsen, KE. Hypertension therpy and risk of coronary heart disease: how do antihypertensives affect metabolic factors? Cardiology 1995; 86, 89 93. 10.1159/000176845 CASPubMedWeb of Science®Google Scholar 81 Warren, JH, Laffel, LMB, Vasania, P et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Int Med 1991; 151, 1350 1356. Web of Science®Google Scholar 82 Curb, JD, Pressel, SL, Cutler, JA et al. Effects of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. J Am Med Assoc 1996; 276, 1886 1892. PubMedWeb of Science®Google Scholar 83 Hansson, L, Lindholm, LH, Niskanen, L et al. Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomised trial. Lancet 1999; 353, 611 616. 10.1016/S0140-6736(98)05012-0 CASPubMedWeb of Science®Google Scholar 84 UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 39. BMJ 1998; 317, 713 720. PubMedWeb of Science®Google Scholar 85 Rasmussen, H. The calcium messenger system. New Engl J Med 1986; 314, 1094 1103. 10.1056/NEJM198604243141707 CASPubMedWeb of Science®Google Scholar 86 Garrison, JC, Borland, MK, Florio, VA, Twible, DA. The role of calcium ion as a mediator of the effects of angiotensin II, catecholamines, and vasopressin on the phosphorylation and activity of enzymes in isolated hepatocytes. J Biol Chem 1997; 254, 7147 7156. PubMedWeb of Science®Google Scholar 87 Fliser, D, Keller, C, Bahrmann, P et al. Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset. J Hypertens 1997; 15, 293 299. 10.1097/00004872-199715030-00011 CASPubMedWeb of Science®Google Scholar 88 Paolisso, G, Tagliamonte, MR, Gambardella, A et al. Losartan mediated improvement in insulin action is mainly due to an increase in non-oxidative glucose metabolism and blood flow in insulin-resistant hypertensive patients. J Hum Hypertens 1997; 11, 307 312. 10.1038/sj.jhh.1000434 CASPubMedWeb of Science®Google Scholar 89 Iyer, SN & Katovich, MJ. Effect of chronic losartan potassium treatment on fructose-induced hypertension. Life Sci.; 55: PL139–PL144., 1995. Google Scholar 90 Hwang, IS, Huang, WC, Wu, JN, Shian, LR, Reaven, GM. Effect of fructose-induced hypertension on the renin-angiotensin-aldosterone system and atrial natriuretic factor. Am J Hypertens 1989; 2, 424 427. CASPubMedWeb of Science®Google Scholar 91 Bhanot, S, McNeill, JH, Bryer-Ash, M. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension 1994; 23, 308 312. 10.1161/01.HYP.23.3.308 CASPubMedWeb of Science®Google Scholar 92 Hwang, I-S, Ho, H, Hoffmann, BB, Reaven, G.M. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10, 512 516. 10.1161/01.HYP.10.5.512 CASPubMedWeb of Science®Google Scholar 93 Reaven, GM, Ho, H, Hoffmann, BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988; 12, 129 132. 10.1161/01.HYP.12.2.129 CASPubMedWeb of Science®Google Scholar 94 Reaven, GM, Ho, H, Hoffmann, BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989; 14, 117 120. 10.1161/01.HYP.14.2.117 CASPubMedWeb of Science®Google Scholar 95 Kobayashi, R, Nagano, M, Nakamura, N et al. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension 1993; 21, 1051 1055. 10.1161/01.HYP.21.6.1051 CASPubMedWeb of Science®Google Scholar 96 Reaven, GM & Chang, H. Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats. Am J Hypertens 1991; 4, 34 38. CASPubMedWeb of Science®Google Scholar 97 Iyer, SN & Katovich, MJ. Effect of acute and chronic losartan treatment on glucose tolerance and insulin sensitivity in fructose-fed rats. Am J Hypertens 1996; 9, 662 668. 10.1016/0895-7061(96)00035-0 CASPubMedWeb of Science®Google Scholar 98 Iimura, O, Shimamoto, K, Nakagawa, M et al. Kinin does not contribute to the improvement of insulin sensitivity in delapril treated fructose fed rats. Am J Hypertens 1995; 8, 181A. 10.1016/0895-7061(95)98044-Y Google Scholar 99 Tomiyama, H, Kushiro, T, Abeta, H et al. Kinins contribute to the improvement of insulin sensitivity during treatement with angiotensin converting enzyme inhibitor. Hypertension 1994; 23, 450 455. 10.1161/01.HYP.23.4.450 CASPubMedWeb of Science®Google Scholar 100 Uehara, M, Kishikawa, H, Isami, S et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994; 37, 300 307. 10.1007/BF00398058 CASPubMedWeb of Science®Google Scholar 101 Iyer, SN & Katovich, MJ. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exper Hypertens 1996; 18, 227 242. 10.3109/10641969609081766 CASPubMedWeb of Science®Google Scholar 102 Iyer, SN, Raizada, MK., Katovich, MJ. AT1 receptor density changes during development of hypertension in hyperinsulinemic rats. Clin Exper Hypertens 1996; 18, 793 810. 10.3109/10641969609081781 CASPubMedWeb of Science®Google Scholar 103 Iyer, SN & Katovich, MJ. Fructose feeding in rats is not associated with sodium retention. Am J Hypertens 1996; 9, 1018 1023. 10.1016/0895-7061(96)00113-6 CASPubMedWeb of Science®Google Scholar 104 Navarro-Cid, J, Maeso, R, Perez-Vizaine, F et al. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension 1995; 26, 1074 1078. 10.1161/01.HYP.26.6.1074 CASPubMedWeb of Science®Google Scholar 105 Verma, S, Bhanot, S, Yao, L et al. Vascular insulin resistance in fructose-hypertensive rats. Eur J Pharmacol 1997; 322, R1 R2. 10.1016/S0014-2999(97)00104-0 CASPubMedWeb of Science®Google Scholar 106 Cheatham, B, Vlahas, CJ, Cheatham, L et al. PI3 kinase activation is required for insulin stimulation of, pp 70, S6 kinase, DNA synthesis and glucose transport translocation. Mol Cell Biol 1994; 14, 4902 4911. 10.1128/MCB.14.7.4902 CASPubMedWeb of Science®Google Scholar 107 Clarke, JF, Young, PW, Yonezawa, K, Kosuga, M, Holman, GD. Inhibition of the translocation of Glut 1 and Glut 4 in 3T3 LI cells by PI3-kinase inhibitor, wortamnnin. Biochem J 1994; 300, 631 635. 10.1042/bj3000631 CASPubMedWeb of Science®Google Scholar 108 Sanches-Margalet, V, Golfine, ID, Vlahas, CJ et al. Role of PI3 kinase in insulin receptor signaling: studies with inhibitor LY294002. Biochem Biophys Res Comm 1994; 204, 446 452. 10.1006/bbrc.1994.2480 PubMedWeb of Science®Google Scholar 109 Tanti, J, Gremeaux, T, Van Obberghen, E, Le-Marchand-Brustel, Y. Serine/threonine phosphorylation of insulin receptor substrate1 modulates insulin receptor signaling. J Biol Chem 1994; 269, 6051 6057. CASPubMedWeb of Science®Google Scholar 110 Mothe, I & Van Obberghen, E. Phosphorylation ofsulin receptor substrate 1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 1996; 271, 11222 11227. 10.1074/jbc.271.19.11222 CASPubMedWeb of Science®Google Scholar 111 Takayama, S, White, MF, Kaln, CR. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J Biol Chem 1998; 263, 3440 3447. PubMedWeb of Science®Google Scholar 112 Velloso, LA, Folli, F, Sun, X et al. Crosstalk between the insulin and angiotensin signaling systems. PNAS 1996; 93, 12490 12495. 10.1073/pnas.93.22.12490 CASPubMedWeb of Science®Google Scholar 113 Hoenack, C & Roesen, P. Inhibition of angiotensin type 1 receptor prevents decline of glucose transporter (Glut 4) in diabetic rat heart. Diabetes 1996; 45 (Suppl.), S82 S87. 10.2337/diab.45.1.S82 PubMedWeb of Science®Google Scholar 114 Moan, A, Hoieggen, A, Seljeflot, I, Risanger, T, Arnesen, H, Kjeldsen, SE. The effects on angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity. J Hypertens 1996; 14, 1093 1097. 10.1097/00004872-199609000-00008 CASPubMedWeb of Science®Google Scholar 115 Chen, S, Noguchi, Y, Izumida, T, Tatebe, J, Katayama, S. A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazone. J Hypertens 1996; 14, 1325 1330. 10.1097/00004872-199611000-00011 CASPubMedWeb of Science®Google Scholar 116 Lerch, M, Teuscher, U, Beissner, P, Schneider, M, Shaw, SC, Weidman, P. Effects of angiotensin II receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents. J Cardiovasc Pharmacol 1998; 31, 576 580. CASPubMedWeb of Science®Google Scholar 117 Shimamato, K, Matsuda, K, Takizawa, H, Higoshiura, K, Ura, N, Iimura, O. Effects of an angiotensin II receptor antagonist, TCV-116, on Insulin Sensitivity in Fructose-Fed Rats. Blood Press. 1994; 5 (Suppl.), 113 116. Google Scholar 118 Chow, I, De Gasparo, M, Levens, N. Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance. Eur J Pharmacol 1997; 319, 77 83. 10.1016/S0014-2999(96)00823-0 CASPubMedWeb of Science®Google Scholar 119 Fogari, R, Zoppi, A, Lazzari, P et al. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 1998; 32, 616 620. 10.1097/00005344-199810000-00014 CASPubMedWeb of Science®Google Scholar 120 Wiggam, MI, Hunter, SJ, Atkinson, AB et al. Captopril does not improve insulin action in essential hypertension: a double blind placebo-controlled study. J Hypertens 1998; 16, 1651 1657. 10.1097/00004872-199816110-00012 CASPubMedWeb of Science®Google Scholar Citing Literature Volume2, Issue1January 2000Pages 3-14 ReferencesRelatedInformation
Referência(s)